Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania

por Codreanu, Cătălin, Popescu, Claudiu C., Mogoşan, Corina
Publicado 2018

Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania

por Codreanu, Cătălin, Mogoșan, Corina, Popescu, Claudiu, Paveliu, Marian-Sorin
Publicado 2019

Comparison of Efficacy and Safety of Original and Biosimilar Adalimumab in Active Rheumatoid Arthritis in a Real-World National Cohort

por Popescu, Claudiu Costinel, Mogoșan, Corina Delia, Enache, Luminița, Codreanu, Cătălin
Publicado 2022

Lung Damage in Rheumatoid Arthritis—A Retrospective Study

por Dinache, Georgiana, Popescu, Claudiu Costinel, Mogoșan, Corina, Enache, Luminita, Agache, Mihaela, Codreanu, Cătălin
Publicado 2022

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

por Michelsen, Brigitte, Østergaard, Mikkel, Nissen, Michael John, Ciurea, Adrian, Möller, Burkhard, Ørnbjerg, Lykke Midtbøll, Zavada, Jakub, Glintborg, Bente, MacDonald, Alan, Laas, Karin, Nordström, Dan, Gudbjornsson, Bjorn, Iannone, Florenzo, Hellmand, Pasoon, Kvien, Tore Kristian, Rodrigues, Ana Maria, Codreanu, Catalin, Rotar, Ziga, Castrejón Fernández, Isabel, Wallman, Johan Karlsson, Vencovsky, Jiri, Loft, Anne Gitte, Heddle, Maureen, Vorobjov, Sigrid, Hokkanen, Anna-Mari, Gröndal, Gerdur, Sebastiani, Marco, van de Sande, Marleen, Kristianslund, Eirik Klami, Santos, Maria José, Mogosan, Corina, Tomsic, Matija, Díaz-González, Federico, Di Giuseppe, Daniela, Hetland, Merete Lund
Publicado 2023